Trials / Completed
CompletedNCT00442234
Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism
Pharmacokinetic/Pharmacodynamic Study of Monteplase ("Cleactor") in Acute Pulmonary Embolism
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To investigate PK and coagulating and fibrinolytic parameter profiles (PD) at the approved dose (13,750 - 27,500 IU/kg) in patients with acute pulmonary embolism accompanying hemodynamic instability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Monteplase |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2007-03-01
- Last updated
- 2018-10-18
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00442234. Inclusion in this directory is not an endorsement.